Reference
Meijboom MJ, et al. RSV vaccine in development: Assessing the potential cost-effectiveness in the Dutch elderly population. Vaccine : 19 Oct 2013. Available from: URL: http://dx.doi.org/10.1016/j.vaccine.2013.10.023
Rights and permissions
About this article
Cite this article
RSV vaccine cost effective in high-risk elderly. PharmacoEcon Outcomes News 691, 9 (2013). https://doi.org/10.1007/s40274-013-0871-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0871-y